Febbraio 2025: Novo Nordisk ha annunciato che il semaglutide 2.4 mg sarebbe stato disponibile nelle farmacie messicane entro aprile 2025, con una perdita di peso media del 17.5% osservata negli studi pivotali
Routine measurement of serum calcitonin (a marker for C-cell pathology) is not recommended by most guidelines, as its value for screening in the general population is limited by poor specificity and the rarity of medullary thyroid carcinoma
While some peptides, such as insulin or GLP-1s like Ozempic, are legal and can be obtained with a doctor's prescription, most fall into a regulatory gray zone and can be sold only as "research" chemicals
Regular follow-up and long-term care help keep blood sugar levels steady, support healthy body weight, and overall health, because GLP-1 medicines alone cannot manage diabetes or obesity 5
Incretin-based multi-agonists, such as tirzepatide and retatrutide, target two or more receptors among GLP-1, GIP, and GCGR to enhance insulin secretion, improve fat metabolism, and increase energy expenditureultimately achieving greater weight loss and metabolic improvement